Here, we reported that B7-H3-mediated resistance was associated with the ability of B7-H3 to inhibit drug-induced CRC cell apoptosis via regulating the G2/M phase in a CDC25A-dependent manner. The gene discussed is CD276; the disease is colorectal carcinoma.